Results from a trial of an mRNA vaccine for pancreatic cancer have shown that the vaccine reduces the chance of the cancer ...
The mRNA vaccine works by targeting genetic mutations found in pancreatic cancer, alerting the immune system to recognize and ...
A Memorial Sloan Kettering phase 1 clinical trial revealed an immune response in some pancreatic cancer patients. Study ...
Memorial Sloan Kettering Cancer Center researchers have found RNA neoantigen vaccines that generate long-lived, functional ...
In a small trial, nearly half of pancreatic cancer patients who received an mRNA vaccine for the disease had no relapse three ...
Clinical studies suggest that the mRNA vaccine may play a role in treating pancreatic cancer, identified as one of the most ...
A new type of mRNA vaccine, added to standard cancer treatment, could help some patients with pancreatic cancer live longer.
In a significant development for pancreatic cancer treatment, a phase 1 clinical trial has highlighted the potential of ...
A promising new mRNA-based vaccine for pancreatic cancer has shown potential in reducing the recurrence of the disease ...